LAMISIL Cream 1%w/w %w/w アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

lamisil cream 1%w/w %w/w

novartis consumer health uk limited - terbinafine hydrochloride - cream - 1%w/w %w/w

LAMISIL Cutaneous Spray Powder 1 %w/w アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

lamisil cutaneous spray powder 1 %w/w

novartis consumer health uk limited - terbinafine hydrochloride - cutaneous spray powder - 1 %w/w

LAMISIL Tablets 250 Milligram アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

lamisil tablets 250 milligram

pco manufacturing - terbinafine hydrochloride - tablets - 250 milligram

LAMISIL AT アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

lamisil at

novartis consumer health uk limited - terbinafine hydrochloride - cream - 1.0 %w/w

LAMISIL ONCE アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

lamisil once

novartis consumer health uk limited - terbinafine hydrochloride - cutaneous solution - 1 per cent

LAMISIL TABLETS 250MG イスラエル - 英語 - Ministry of Health

lamisil tablets 250mg

novartis pharma services ag - terbinafine hydrochloride 281.25 mg - tablets - terbinafine - fungal infections of the skin caused by dermatophytes such as trichophyton (e.g. rubrum, t. mentagrophytes, t. verrucosum, t. violaceum), microsporum canis and epidermophyton floccosum. oral lamisil should only be used to treat extensive, severe ringworm infections ( tinea corporis, tinea cruris and tinea pedis). oral lamisil is not effective against vaginal candidiasis or pityriasis (tinea) versicolor. onychomycoses ( tinea unguium, ringworm of the nails) due to infecton with dermatophyte organisms ( hyphomycetes).

LAMISIL TABLETS 250MG イスラエル - 英語 - Ministry of Health

lamisil tablets 250mg

novartis pharma services ag - terbinafine hydrochloride 281.25 mg - tablets - terbinafine - fungal infections of the skin caused by dermatophytes such as trichophyton (e.g. rubrum, t. mentagrophytes, t. verrucosum, t. violaceum), microsporum canis and epidermophyton floccosum. oral lamisil should only be used to treat extensive, severe ringworm infections ( tinea corporis, tinea cruris and tinea pedis). oral lamisil is not effective against vaginal candidiasis or pityriasis (tinea) versicolor. onychomycoses ( tinea unguium, ringworm of the nails) due to infecton with dermatophyte organisms ( hyphomycetes).

LAMISIL 1 %w/w Cutaneous Solution アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

lamisil 1 %w/w cutaneous solution

novartis pharmaceuticals uk ltd - terbinafine hydrochloride - cutaneous solution - 1 %w/w - antifungals for systemic use